Effects of Bifidobacterium breve A1 on the cognitive function of older adults with memory complaints: a randomised, double-blind, placebo-controlled trial

SLAB51 Probiotic Formulation Activates SIRT1 Pathway Promoting Antioxidant and Neuroprotective Effects in an AD Mouse Model

(2018) Laura Bonfili et al.   MOLECULAR NEUROBIOLOGY

Therapeutic potential of Bifidobacterium breve strain A1 for preventing cognitive impairment in Alzheimer’s disease

(2017) Yodai Kobayashi et al.   Scientific Reports

The Central Nervous System and the Gut Microbiome

(2016) Gil Sharon et al.   CELL

Human gut microbiota: the links with dementia development

(2016) Rashad Alkasir et al.   Protein & Cell

Control of Brain Development, Function, and Behavior by the Microbiome

(2015) Timothy R. Sampson et al.   Cell Host & Microbe

The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): Utility in Detection and Characterization of Mild Cognitive Impairment due to Alzheimer's Disease

(2013) S. Karantzoulis et al.   ARCHIVES OF CLINICAL NEUROPSYCHOLOGY

Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour

(2012) John F. Cryan et al.   NATURE REVIEWS NEUROSCIENCE

Increased binding of peripheral benzodiazepine receptor in mild cognitive impairment–dementia converters measured by positron emission tomography with [11C]DAA1106

(2012) Fumihiko Yasuno et al.   PSYCHIATRY RESEARCH-NEUROIMAGING

Probiotics and the gut microbiota in intestinal health and disease

(2010) Mélanie G. Gareau et al.   Nature Reviews Gastroenterology & Hepatology

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

(2009) Clifford R Jack et al.   LANCET NEUROLOGY

Cross validation of the Montreal Cognitive Assessment in community dwelling older adults residing in the Southeastern US

(2008) Cheryl A. Luis et al.   INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY